GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verastem Inc (FRA:2VSA) » Definitions » Price-to-Free-Cash-Flow

Verastem (FRA:2VSA) Price-to-Free-Cash-Flow : N/A (As of Jun. 21, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Verastem Price-to-Free-Cash-Flow?

As of today (2024-06-21), Verastem's share price is €3.04. Verastem's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €-3.60. Hence, Verastem's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Verastem's Price-to-Free-Cash-Flow or its related term are showing as below:

FRA:2VSA's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 34.32
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Verastem's Free Cash Flow per Share for the three months ended in Mar. 2024 was €-0.97. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was €-3.60.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -14.30% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 29.40% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 16.00% per year.

During the past 13 years, Verastem's highest 3-Year average Free Cash Flow per Share Growth Rate was 47.30% per year. The lowest was -44.80% per year. And the median was -0.35% per year.


Verastem Price-to-Free-Cash-Flow Historical Data

The historical data trend for Verastem's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verastem Price-to-Free-Cash-Flow Chart

Verastem Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Verastem Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Verastem's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Verastem's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Verastem's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Verastem's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Verastem's Price-to-Free-Cash-Flow falls into.



Verastem Price-to-Free-Cash-Flow Calculation

Verastem's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=3.04/-3.6
=N/A

Verastem's Share Price of today is €3.04.
Verastem's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3.60.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Verastem  (FRA:2VSA) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Verastem Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Verastem's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Verastem (FRA:2VSA) Business Description

Traded in Other Exchanges
Address
117 Kendrick Street, Suite 500, Needham, MA, USA, 02494
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Verastem (FRA:2VSA) Headlines

No Headlines